Negative psychotic symptoms and impaired role functioning predict transition outcomes in the at-risk mental state:A latent class cluster analysis study

Psychological Medicine

Volumn 43, Issue 11, 2013, Pages 2311-2325

  Valmaggia, L R ^a,b   Stahl, D ^a   Yung, A R ^c,d   Nelson, B ^c   Fusar Poli, P ^a,b   McGorry, P D ^c   McGuire, P K ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

At risk mental state; Early detection; Early intervention; Negative symptoms; Psychosis

Indexed keywords

ADOLESCENT; ADULT; AGE; ANHEDONIA; APATHY; APHASIA; ARTICLE; CLUSTER ANALYSIS; DISEASE COURSE; EARLY DIAGNOSIS; EARLY INTERVENTION; EMPLOYMENT; FEMALE; HUMAN; MALE; PRODROMAL SYMPTOM; PSYCHOLOGICAL ASPECT; PSYCHOSIS; RISK ASSESSMENT; RISK FACTOR; SOCIAL ISOLATION; STATISTICS; UNEMPLOYMENT; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; ANHEDONIA; APATHY; APHASIA; CLUSTER ANALYSIS; DISEASE PROGRESSION; EARLY DIAGNOSIS; EARLY MEDICAL INTERVENTION; EMPLOYMENT; FEMALE; HUMANS; MALE; PRODROMAL SYMPTOMS; PSYCHOTIC DISORDERS; RISK ASSESSMENT; RISK FACTORS; SOCIAL ISOLATION; UNEMPLOYMENT; YOUNG ADULT;

EID: 84884351080     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291713000251     Document Type: Article

References (74)

1. Amminger GP, Leicester S, Yung AR, Phillips LJ, Berger GE, Francey SM, Yuen HP, McGorry PD (2006). Early-onset of symptoms predicts conversion to non-affective psychosis in ultra-high risk individuals. Schizophrenia Research 84, 67-76.
2. Andreasen NC, Carpenter WT Jr. (1993). Diagnosis and classification of schizophrenia. Schizophrenia Bulletin 19, 199-214.
3. APA (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association:Washington, DC.
4. Bentall RP, Jackson HF, Pilgrim D (1988). Abandoning the concept of 'schizophrenia':some implications of validity arguments for psychological research into psychotic phenomena. British Journal of Clinical Psychology 27, 303-324.
5. Buchanan RW, Carpenter WT Jr. (1997). The neuroanatomies of schizophrenia. Schizophrenia Bulletin 23, 367-372.
6. Cannon TD, Cadenhead K, Cornblatt B, Woods SW, Addington J, Walker E, Seidman LJ, Perkins D, Tsuang M, McGlashan T, Heinssen R (2008). Prediction of psychosis in youth at high clinical risk:a multisite longitudinal study in North America. Archives of General Psychiatry 65, 28-37.
7. Castle DJ, Sham PC, Wessely S, Murray RM (1994). The subtyping of schizophrenia in men and women:a latent class analysis. Psychological Medicine 24, 41-51.
8. Cornblatt BA, Auther AM, Niendam T, Smith CW, Zinberg J, Bearden CE, Cannon TD (2007). Preliminary findings for two new measures of social and role functioning in the prodromal phase of schizophrenia. Schizophrenia Bulletin 33, 688-702.
9. Cornblatt BA, Lencz T, Smith CW, Correll CU, Auther AM, Nakayama E (2003). The schizophrenia prodrome revisited:a neurodevelopmental perspective. Schizophrenia Bulletin 29, 633-651.
10. Davidsen KA (2009). Anomalous self-experience in adolescents at risk of psychosis. Clinical and conceptual elucidation. Psychopathology 42, 361-369.
11. Demjaha A, Valmaggia L, Stahl D, Byrne M, McGuire P (2012). Disorganization/cognitive and negative symptom dimensions in the at-risk mental state predict subsequent transition to psychosis. Schizophrenia Bulletin 38, 351-359.
12. French P, Morrison AP (2004). Early Detection and Cognitive Therapy for People at High Risk of Developing Psychosis:A Treatment Approach. Wiley-Blackwell:Chichester.
13. Fusar-Poli P, Bonoldi I, Yung AR, Borgwardt S, Kempton MJ, Valmaggia L, Barale F, Caverzasi E, McGuire P (2012a). Predicting psychosis meta-analysis of transition outcomes in individuals at high clinical risk. Archives of General Psychiatry 69, 220-229.
14. Fusar-Poli P, Borgwardt S, Bechdolf A, Addington J, Riecher-Rossler A, Schultze-Lutter F, Keshavan M, Wood S, Ruhrmann S, Seidman LJ, Valmaggia L, Cannon T, Velthorst E, de Haan L, Cornblatt B, Bonoldi I, Birchwood M, McGlashan T, Carpenter W, McGorry P, Klosterkotter J, McGuire P, Yung A (2012b). The psychosis high-risk state:a comprehensive state-of-the-art review. Archieves of General Psychiatry. Published online:19 November 2012. doi:10.1001/ jamapsychiatry.2013.269.
15. Fusar-Poli P, Byrne M, Badger S, Valmaggia LR, McGuire PK (2012c). Outreach and support in South London (OASIS), 2001-2011:ten years of early diagnosis and treatment for young individuals at high clinical risk for psychosis. European Psychiatry. Published online:5 November 2012. doi:10.1016/j.eurpsy.2012.08.002.
16. Fusar-Poli P, Byrne M, Valmaggia L, Day F, Tabraham P, Johns L, McGuire P (2010). Social dysfunction predicts two years clinical outcome in people at ultra high risk for psychosis. Journal of Psychiatric Research 44, 294-301.
17. Fusar-Poli P, Deste G, Smieskova R, Barlati S, Yung AR, Howes O, Stieglitz RD, Vita A, McGuire P, Borgwardt S (2012d). Cognitive functioning in prodromal psychosis:a meta-analysis. Archives of General Psychiatry 69, 562-571.
18. Fusar-Poli P, Meneghelli A, Valmaggia L, Allen P, Galvan F, McGuire P, Cocchi A (2009). Duration of untreated prodromal symptoms and 12-month functional outcome of individuals at risk of psychosis. British Journal of Psychiatry 194, 181-182.
19. Fusar-Poli P, Nelson B, Valmaggia L, Yung AR, McGuire PK (2012e). Comorbid depressive and anxiety disorders in 509 individuals with an at-risk mental state:impact on psychopathology and transition to psychosis. Schizophrenia Bulletin. Published online:22 November 2012. doi:10.1093/schbul/ sbs13.
20. Fusar-Poli P, Valmaggia L, McGuire P (2007). Can antidepressants prevent psychosis? Lancet 370, 1746-1748.
21. Garety PA, Kuipers E, Fowler D, Freeman D, Bebbington PE (2001). A cognitive model of the positive symptoms of psychosis. Psychological Medicine 31, 189-195.
22. Herbener ES, Harrow M (2004). Are negative symptoms associated with functioning deficits in both schizophrenia and nonschizophrenia patients? A 10-year longitudinal analysis. Schizophrenia Bulletin 30, 813-825.
23. Klosterkotter J, Schultze-Lutter F, Bechdolf A, Ruhrmann S (2011). Prediction and prevention of schizophrenia:what has been achieved and where to go next? World Psychiatry 10, 165-174.
24. Larsen TK, Friis S, Haahr U, Johannessen JO, Melle I, Opjordsmoen S, Rund BR, Simonsen E, Vaglum PV, McGlashan TH (2004). Premorbid adjustment in first-episode non-affective psychosis:distinct patterns of pre-onset course. British Journal of Psychiatry 185, 108-115.
25. Lataster T, Valmaggia L, Lardinois M, van Os J, Myin-Germeys I (2012). Increased stress reactivity:a mechanism specifically associated with the positive symptoms of psychotic disorder. Psychological Medicine. Published online:31 October. doi:10.1017/S0033291712002279.
26. Lazarsfeld PF, Henry NW (1968). Latent Structure Analysis. Wiley:New York.
27. Lencz T, Smith CW, Auther A, Correll CU, Cornblatt B (2004). Nonspecific and attenuated negative symptoms in patients at clinical high-risk for schizophrenia. Schizophrenia Research 68, 37-48.
28. Lin TH, Dayton CM (1997). Model selection information criteria for non-nested latent class models. Journal of Educational and Behavioral Statistics 22, 249-264.
29. Maric N, Krabbendam L, Vollebergh W, de Graaf R, van Os J (2003). Sex differences in symptoms of psychosis in a non-selected, general population sample. Schizophrenia Research 63, 89-95.
30. Masillo A, Day F, Laing J, Howes O, Fusar-Poli P, Byrne M, Bhattacharyya S, Fiori Nastro P, Girardi P, McGuire PK, Valmaggia LR (2012). Interpersonal sensitivity in the at-risk mental state for psychosis. Psychological Medicine 42, 1835-1845.
31. McGlashan TH, Addington J, Cannon T, Heinimaa M, McGorry P, O'Brien M, Penn D, Perkins D, Salokangas RK, Walsh B, Woods SW, Yung A (2007). Recruitment and treatment practices for help-seeking 'prodromal' patients. Schizophrenia Bulletin 33, 715-726.
32. McGlashan TH, Fenton WS (1992). The positive-negative distinction in schizophrenia. Review of natural history validators. Archives of Geneneral Psychiatry 49, 63-72.
33. McGlashan TH, Johannessen JO (1996). Early detection and intervention with schizophrenia:rationale. Schizophrenia Bulletin 22, 201-222.
34. McLachlan GJ, Peel D (2000). Finite Mixture Models. Wiley:New York.
35. Meng H, Schimmelmann BG, Koch E, Bailey B, Parzer P, Gunter M, Mohler B, Kunz N, Schulte-Markwort M, Felder W, Zollinger R, Burgin D, Resch F (2009). Basic symptoms in the general population and in psychotic and non-psychotic psychiatric adolescents. Schizophrenia Research 111, 32-38.
36. Miller TJ, Zipursky RB, Perkins D, Addington J, Woods SW, Hawkins KA, Hoffman R, Preda A, Epstein I, Addington D, Lindborg S, Marquez E, Tohen M, Breier A, McGlashan TH (2003). The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the 'prodromal' sample. Schizophrenia Research 61, 19-30.
37. Morrison AP, French P, Parker S, Roberts M, Stevens H, Bentall RP, Lewis SW (2007). Three-year follow-up of a randomized controlled trial of cognitive therapy for the prevention of psychosis in people at ultrahigh risk. Schizophrenia Bulletin 33, 682-687.
38. Muthén BO, Muthén LK (2000). The development of heavy drinking and alcohol-related problems from ages 18 to 37 in a U.S. national sample. Journal of Studies on Alcohol 61, 290-300.
39. Muthén LK, Muthén BO (2006). Mplus:Statistical Analysis with Latent Variables (Version 4.1). Muthen & Muthen:Los Angeles, CA.
40. Myin-Germeys I, van Os J (2007). Stress-reactivity in psychosis:evidence for an affective pathway to psychosis. Clinical Psychology Review 27, 409-424.
41. Nelson B, Fornito A, Harrison BJ, Yücel M, Sass LA, Yung AR, Thompson A, Wood SJ, Pantelis C, McGorry PD (2009a). A disturbed sense of self in the psychosis prodrome:linking phenomenology and neurobiology. Neuroscience and Biobehavioral Reviews 33, 807-817.
42. Nelson B, Sass LA, Skodlar B (2009b). The phenomenological model of psychotic vulnerability and its possible implications for psychological interventions in the ultra-high risk ('prodromal') population. Psychopathology 42, 283-292.
43. Parnas J (2011). A disappearing heritage:the clinical core of schizophrenia. Schizophrenia Bulletin 37, 1121-1130.
44. Parnas J, Handest P (2003). Phenomenology of anomalous self-experience in early schizophrenia. Comprehensive Psychiatry 44, 121-134.
45. Phillips LJ, McGorry PD, Yuen HP, Ward J, Donovan K, Kelly D, Francey SM, Yung AR (2007). Medium term follow-up of a randomized controlled trial of interventions for young people at ultra high risk of psychosis. Schizophrenia Research 96, 25-33.
46. Phillips LJ, Yung AR, McGorry PD (2000). Identification of young people at risk of psychosis:validation of Personal Assessment and Crisis Evaluation Clinic intake criteria. Australian and New Zealand Journal of Psychiatry 34, S164-S169.
47. Phillips LJ, Yung AR, Yuen HP, Pantelis C, McGorry PD (2002). Prediction and prevention of transition to psychosis in young people at incipient risk for schizophrenia. American Journal of Medical Genetics 114, 929-937.
48. Raballo A, Laroi F (2011). Psychosis risk syndrome and DSM-5:time for a dimensional approach to at-risk mental states? Clinical Schizophrenia and Related Psychoses 5, 155-158.
49. Raine A (1992). Sex differences in schizotypal personality in a non-clinical population. Journal of Abnormal Psychology 101, 361-364.
50. Riecher-Rossler A, Gschwandtner U, Aston J, Borgwardt S, Drewe M, Fuhr P, Pfluger M, Radu W, Schindler C, Stieglitz RD (2007). The Basel early-detection-of-psychosis (FEPSY)-study-design and preliminary results. Acta Psychiatrica Scandinavica 115, 114-125.
51. Riecher-Rossler A, Pflueger MO, Aston J, Borgwardt SJ, Brewer WJ, Gschwandtner U, Stieglitz RD (2009). Efficacy of using cognitive status in predicting psychosis:a 7-year follow-up. Biological Psychiatry 66, 1023-1030.
52. Roy MA, Maziade M, Labbe A, Merette C (2001). Male gender is associated with deficit schizophrenia:a meta-analysis. Schizophrenia Research 47, 141-147.
53. Ruhrmann S, Schultze-Lutter F, Salokangas RK, Heinimaa M, Linszen D, Dingemans P, Birchwood M, Patterson P, Juckel G, Heinz A, Morrison A, Lewis S, von Reventlow HG, Klosterkotter J (2010). Prediction of psychosis in adolescents and young adults at high risk:results from the prospective European prediction of psychosis study. Archives of General Psychiatry 67, 241-251.
54. Schultz SK, Miller DD, Oliver SE, Arndt S, Flaum M, Andreasen NC (1997). The life course of schizophrenia:age and symptom dimensions. Schizophrenia Research 23, 15-23.
55. Seidman LJ, Giuliano AJ, Meyer EC, Addington J, Cadenhead KS, Cannon TD, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW, Bearden CE, Christensen BK, Hawkins K, Heaton R, Keefe RSE, Heinssen R, Cornblatt BA; North American Prodrome Longitudinal Study (NAPLS) Group (2010). Neuropsychology of the prodrome to psychosis in the NAPLS consortium:relationship to family history and conversion to psychosis. Archives of General Psychiatry 67, 578-588.
56. Sham PC, Castle DJ, Wessely S, Farmer AE, Murray RM (1996). Further exploration of a latent class typology of schizophrenia. Schizophrenia Research 20, 105-115.
57. Simon AE, Umbricht D (2010). High remission rates from an initial ultra-high risk state for psychosis. Schizophrenia Research 116, 168-172.
58. Simon AE, Velthorst E, Nieman DH, Linszen D, Umbricht D, de Haan L (2011). Ultra high-risk state for psychosis and non-transition:a systematic review. Schizophrenia Research 132, 8-17.
59. Skrondal A, Rabe-Hesketh S (2004). Generalized Latent Variable Modeling:Multilevel, Longitudinal, and Structural Equation Models. CRC Press:Bocca Raton, FL.
60. Smieskova R, Allen P, Simon A, Aston J, Bendfeldt K, Drewe J, Gruber K, Gschwandtner U, Klarhoefer M, Lenz C, Scheffler K, Stieglitz RD, Radue EW, McGuire P, Riecher-Rossler A, Borgwardt SJ (2011). Different duration of at-risk mental state associated with neurofunctional abnormalities. A multimodal imaging study. Human Brain Mapping 33, 2281-2294.
61. Turkington D, Morrison AP (2012). Cognitive therapy for negative symptoms of schizophrenia. Archives of General Psychiatry 69, 119-120.
62. van Os J, Linscott RJ (2012). The extended psychosis phenotype- relationship with schizophrenia and with ultrahigh risk status for psychosis. Schizophrenia Bulletin 38, 227-230.
63. van Os J, Linscott RJ, Myin-Germeys I, Delespaul P, Krabbendam L (2009). A systematic review and meta-analysis of the psychosis continuum:evidence for a psychosis proneness-persistence-impairment model of psychotic disorder. Psychological Medicine 39, 179-195.
64. Velthorst E, Nieman DH, Klaassen RM, Becker HE, Dingemans PM, Linszen DH, de Haan L (2011). Three-year course of clinical symptomatology in young people at ultra high risk for transition to psychosis. Acta Psychiatrica Scandinavica 123, 36-42.
65. Velthorst E, Nieman DH, Linszen D, Becker H, de Haan L, Dingemans PM, Birchwood M, Patterson P, Salokangas RK, Heinimaa M, Heinz A, Juckel G, von Reventlow HG, French P, Stevens H, Schultze-Lutter F, Klosterkotter J, Ruhrmann S (2010). Disability in people clinically at high risk of psychosis. British Journal of Psychiatry 197, 278-284.
66. Vermunt JJ, Parkinson TJ (2002). Claw lameness in dairy cattle:New Zealand-based research. New Zealand Veterinary Journal 50, 88-89.
67. Yung A, Phillips LJ, McGorry P (2004). Treating Schizophrenia in the Prodromal Phase. Taylor & Francis:London.
68. Yung AR, McGorry PD (1996a). The initial prodrome in psychosis: descriptive and qualitative aspects. Australian and New Zealand Journal of Psychiatry 30, 587-599.
69. Yung AR, McGorry PD (1996b). The prodromal phase of first-episode psychosis:past and current conceptualizations. Schizophrenia Bulletin 22, 353-370.
70. Yung AR, Nelson B, Thompson A, Wood SJ (2010). The psychosis threshold in ultra high risk (prodromal) research:is it valid? Schizophrenia Research 120, 1-6.
71. Yung AR, Phillips LJ, McGorry PD, McFarlane CA, Francey S, Harrigan S, Patton GC, Jackson HJ (1998). Prediction of psychosis. A step towards indicated prevention of schizophrenia. British Journal of Psychiatry. Supplement 172, 14-20.
72. Yung AR, Woods SW, Ruhrmann S, Addington J, Schultze-Lutter F, Cornblatt BA, Amminger GP, Bechdolf A, Birchwood M, Borgwardt S, Cannon TD, de Haan L, French P, Fusar-Poli P, Keshavan M, Klosterkotter J, Kwon JS, McGorry PD, McGuire P, Mizuno M, Morrison AP, Riecher-Rossler A, Salokangas RKR, Seidman LJ, Suzuki M, Valmaggia L, van der Gaag M,Wood SJ, McGlashan TH (2012). Whither the attenuated psychosis syndrome? Schizophrenia Bulletin 38, 1130-1134.
73. Yung AR, Yuen HP, Berger G, Francey S, Hung TC, Nelson B, Phillips L, McGorry P (2007). Declining transition rate in ultra high risk (prodromal) services:dilution or reduction of risk? Schizophrenia Bulletin 33, 673-681.
74. Yung AR, Yuen HP, McGorry PD, Phillips LJ, Kelly D, Dell'Olio M, Francey SM, Cosgrave EM, Killackey E, Stanford C, Godfrey K, Buckby J (2005). Mapping the onset of psychosis:the Comprehensive Assessment of At-Risk Mental States. Australian and New Zealand Journal of Psychiatry 39, 964-971.